---
title: "Syncom Formulations (India) Ltd (SYNCOMF) — Share Price, Financials & Analysis"
symbol: "SYNCOMF"
company: "Syncom Formulations (India) Ltd"
canonical: "https://tapetide.com/stocks/SYNCOMF"
isin: "INE312C01025"
nse_symbol: "SYNCOMF"
bse_code: "524470"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 1757.8
generated_at: "2026-09-13T18:59:16.270Z"
---

# Syncom Formulations (India) Ltd (SYNCOMF)

Canonical page: https://tapetide.com/stocks/SYNCOMF

## Company

- **NSE Symbol:** SYNCOMF
- **BSE Code:** 524470
- **ISIN:** INE312C01025
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2022-11-18
- **CEO:** Mr. Ankit Kedarmal Bankda
- **Employees:** 744
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** syncomformulations.com

## About

Established in the year 1995, Syncom Formulations is a global pharmaceutical company that manufactures and markets a broad range of healthcare products. The company is a generic pharmaceutical player operating in more than 15 countries worldwide having more than 400 products registered.[1]

## Latest Price

- **Price:** ₹19.46
- **Change:** +0.2 (+1.04%)
- **Open:** ₹18.98
- **Day High:** ₹20.1
- **Day Low:** ₹18.51
- **Previous Close:** ₹19.26
- **Volume:** 9148018
- **As Of:** 2026-09-11T10:28:09+00:00

## Key Fundamentals

Observed at 2026-09-11T04:45:14.245049Z.

- **Market Cap:** ₹1757.8 Cr
- **Classification:** Microcap
- **P/E (reported):** 21.2
- **P/E (TTM):** 21.62
- **EPS (TTM):** ₹0.9
- **Book Value:** ₹4.41
- **Price to Book:** 4.38
- **Dividend Yield:** 0.52%
- **ROE:** 14.45%
- **ROCE:** 18.75%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹489.17 Cr
- **Net Income:** ₹78.25 Cr
- **EBITDA:** ₹77.43 Cr
- **52-Week High:** ₹22.59
- **52-Week Low:** ₹10.21
- **RSI (14):** 59.49

## Tapetide Score

- **Score:** 58 / 100
- **Score date:** 2026-09-04
- **Archetype:** Average Quality, Undemanding Price
- **What it means:** The financials sit mid-range rather than strong, and the multiple is not demanding. Nothing here stands out in either direction, so the read comes down to which single pillar you weight most and whether the next results move it off the middle.
- **Pillar profile:** Quality: Average · Valuation: Cheap · Momentum: Rising
- **Percentile:** 81.3 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 88.88 | 9% |
| growth | 11.68 | 9% |
| momentum | 89.4 | 12% |
| ownership | 57.78 | 24% |
| quality | 55.12 | 22% |
| valuation | 70.11 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 21.2% CAGR over last 5 years

### Weaknesses

- Earnings include an other income of Rs.32.8 Cr.
- Working capital days have increased from 103 days to 164 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 493.29% | 122.6% | 69.36% |
| ebitda margin growth | -7.1% | 0.27% | -4.62% | 7.52% |
| net income growth | -1.19% | 58.4% | 56% | 21% |
| revenue growth | -11.07% | 1.4% | 30% | 15% |
| roce | -4.67% | 45.46% | 67.11% | 13.6% |
| roe | -1.27% | 64.39% | 10.36% | 60.91% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 62 | 63 | 73 | 87 | 101 | 127 | 148 | 117 | 121 | 115 | 134 | 125 |
| Expenses | 56 | 57 | 64 | 76 | 90 | 112 | 131 | 101 | 103 | 93 | 113 | 99 |
| Operating Profit | 6 | 7 | 9 | 10 | 12 | 15 | 17 | 16 | 19 | 21 | 21 | 26 |
| OPM % | 10 | 11 | 12 | 12 | 12 | 11 | 12 | 14 | 15 | 18 | 16 | 21 |
| Other Income | 4 | 4 | 3 | 1 | 4 | 4 | 7 | 6 | 5 | 5 | 14 | 8 |
| Interest | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | 8 | 9 | 9 | 10 | 15 | 17 | 23 | 20 | 22 | 25 | 33 | 32 |
| Tax % | 24 | 25 | 27 | 24 | 25 | 24 | 24 | 22 | 25 | 25 | 25 | 23 |
| Net Profit | 6 | 6 | 7 | 8 | 11 | 13 | 18 | 16 | 17 | 19 | 25 | 25 |
| EPS in Rs | 0.07 | 0.07 | 0.07 | 0.08 | 0.12 | 0.14 | 0.19 | 0.17 | 0.18 | 0.2 | 0.26 | 0.26 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 159 | 187 | 206 | 245 | 216 | 222 | 257 | 461 | 487 | 495 |
| Expenses | 147 | 175 | 189 | 207 | 196 | 202 | 229 | 407 | 409 | 407 |
| Operating Profit | 12 | 12 | 17 | 38 | 20 | 20 | 28 | 54 | 77 | 87 |
| OPM % | 7 | 6 | 8 | 16 | 9 | 9 | 11 | 12 | 16 | 18 |
| Other Income | 4 | 5 | 5 | 7 | 12 | 15 | 13 | 17 | 31 | 33 |
| Interest | 0 | 0 | 1 | 0 | 2 | 3 | 5 | 1 | 1 | 1 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 7 | 7 |
| Profit before tax | 12 | 13 | 17 | 41 | 26 | 27 | 32 | 65 | 101 | 112 |
| Tax % | 28 | 12 | 18 | 28 | 24 | 24 | 26 | 24 | 24 | — |
| Net Profit | 9 | 11 | 14 | 29 | 20 | 20 | 24 | 49 | 76 | 85 |
| EPS in Rs | 0.11 | 0.14 | 0.18 | 0.37 | 0.23 | 0.21 | 0.25 | 0.52 | 0.81 | 0.9 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 13 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 78 | 78 | 78 | 78 | 79 | 86 | 94 | 94 | 94 | 94 |
| Reserves | 36 | 44 | 55 | 68 | 109 | 136 | 162 | 192 | 246 | 318 |
| Borrowings | 12 | 12 | 9 | 2 | 62 | 58 | 83 | 72 | 4 | 1 |
| Other Liabilities | 48 | 37 | 32 | 33 | 42 | 28 | 38 | 33 | 66 | 116 |
| Total Liabilities | 175 | 171 | 173 | 181 | 292 | 308 | 377 | 392 | 410 | 529 |
| Fixed Assets | 85 | 89 | 89 | 93 | 91 | 94 | 91 | 120 | 125 | 184 |
| CWIP | 0 | 1 | 0 | 0 | 0 | 6 | 26 | 0 | 0 | 0 |
| Investments | 1 | 2 | 2 | 1 | 11 | 43 | 64 | 66 | 93 | 109 |
| Other Assets | 89 | 79 | 83 | 87 | 189 | 165 | 196 | 206 | 192 | 237 |
| Total Assets | 175 | 171 | 173 | 181 | 292 | 308 | 377 | 392 | 410 | 529 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 17 | -2 | 4 | 6 | -2 | 16 | 10 | -6 | 23 | 58 |
| Cash from Investing Activity | -8 | -2 | 2 | 2 | -75 | -27 | -45 | 84 | -18 | -51 |
| Cash from Financing Activity | -2 | -2 | 0 | -7 | 72 | 8 | 35 | -15 | -68 | -3 |
| Net Cash Flow | 6 | -6 | 7 | 1 | -5 | -2 | 1 | 63 | -63 | 4 |
| Free Cash Flow | 9 | -8 | 10 | 4 | -5 | 5 | -10 | -14 | 13 | 47 |
| CFO/OP | 128 | 13 | 66 | 61 | 24 | 113 | 86 | 6 | 70 | 105 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 91 | 87 | 81 | 77 | 112 | 114 | 124 | 132 | 85 | 81 |
| Inventory Days | 29 | 37 | 37 | 39 | 51 | 51 | 53 | 49 | 49 | 81 |
| Days Payable | 92 | 75 | 57 | 49 | 66 | 36 | 52 | 33 | 51 | 96 |
| Cash Conversion Cycle | 27 | 49 | 61 | 67 | 96 | 129 | 124 | 148 | 83 | 66 |
| Working Capital Days | 45 | 75 | 74 | 88 | 28 | 33 | -4 | 51 | 95 | 164 |
| ROCE % | 14 | 9 | 9 | 12 | 21 | 11 | 10 | 10 | 19 | 27 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% |
| FIIs | 0% | 0% | 0.08% | 0.09% | 0.1% | 0.13% | 0.11% | 0.41% | 0.1% | 0.26% | 0.21% | 0.35% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 44.76% | 44.82% | 44.85% | 45.08% | 45.14% | 45.06% | 45.2% | 44.83% | 45.21% | 45.04% | 45.15% | 44.9% |
| Others | 4.67% | 4.61% | 4.5% | 4.27% | 4.18% | 4.24% | 4.12% | 4.19% | 4.12% | 4.13% | 4.06% | 4.18% |
| No. of Shareholders | 224252 | 289982 | 325761 | 376530 | 469242 | 489520 | 484529 | 471066 | 457364 | 442280 | 431690 | 422114 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 5 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 20.3 | Sell |
| EMA (10) | 19.67 | Sell |
| SMA (20) | 18.46 | Buy |
| EMA (20) | 18.62 | Buy |
| SMA (50) | 15.62 | Buy |
| EMA (50) | 16.63 | Buy |
| SMA (100) | 14.94 | Buy |
| EMA (100) | 15.47 | Buy |
| SMA (200) | 14.17 | Buy |
| EMA (200) | 15.14 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 60.56 | Neutral |
| MACD (12,26,9) | 1.43 | Sell |
| Stochastic (14,3,3) | 52.82 | Neutral |
| ADX (14) | 52.9 | Buy |
| Williams %R (14) | -54.53 | Neutral |
| ATR (14) | 1.21 | High Volatility |
| ROC (12) | 14.27 | Buy |
| Stoch RSI (14) | 4.18 | Buy |
| UO (7,14,28) | 43.03 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fef6c2c0-9697-4363-aa8e-5951cba320b9.pdf) |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d390401b-45fd-46d2-abfc-87270ce71303.pdf) |
| 2026-09-07 | [Submission Of The Notice Of 38Th Annual General Meeting To Be Held On Wednesday 30Th September 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35cb430d-e9e0-40fd-9e74-adb48fedfb58.pdf) |
| 2026-09-07 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=582f9997-1df9-4b76-ab8f-3b6d4e73fcb0.pdf) |
| 2026-09-07 | [Regulation 36(1)(B) Of The SEBI (LODR) Regulations 2015- Dispatch Of Letters To Shareholders Who Have Not Registered Their Email Addresses.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d774367d-a1b1-4765-8342-554dff5f5ac6.pdf) |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33fb2705-159d-4911-902f-f5c7c63b72b5.pdf) |
| 2026-08-13 | [Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015(Listing Regulations): Press Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08deab29-6e57-432a-9adc-3cb0b2281153.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fe826df-304f-4cac-acd4-11c41ac0eebc.pdf) |
| 2026-08-11 | [Board Meeting Outcome for Outcome Of The 2/2026-27 Meeting Of The Board Of Directors Of The Company.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22fab449-8d97-4d29-8f46-ff33e5041a3e.pdf) |
| 2026-08-11 | [Corporate Action-Board approves Dividend](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6db1697-7e93-4912-b723-f32dff94c914.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-11 | [Regulation 33(3) Of SEBI (LODR) Regulations 2015- Submission Of The Un-Audited Standalone And Consolidated Financial Results Along With Limited Review Report Thereon For The Quarter Ended 30Th June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96c5161f-7015-4a7a-97a1-f91c019487fd.pdf) |
| 2026-05-22 | [Regulation 33(3)(D) Of SEBI (LODR) Regulations 2015-Submission Of Standalone & Consolidated Audited Financial Results Along With Audit Report Statement Of Assets And Liabilities And Cash Flow For The Year Ended On 31St March 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9732abb-bc02-4db1-a643-187b7e34e069.pdf) |
| 2026-02-12 | [Regulation 33(3) Of SEBI (LODR) Regulations 2015 - Submission Of Standalone & Consolidated Unaudited Financial Results Along With Limited Review Report For The Quarter And Nine Months Ended On 31St December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7ac2684-5731-448b-aaf3-d6750343ed30.pdf) |
| 2025-11-12 | [Regulation 33(3) Of SEBI (LODR) Regulations 2015 - Submission Of Standalone & Consolidated Unaudited Financial Results .](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32ba362f-3bbc-4fac-9363-41ac21e00df2.pdf) |
| 2025-08-08 | [Results- Financial Results 30.06.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9401fe1b-4cb9-48a1-8b63-b916a3defe74.pdf) |
| 2025-05-19 | [Results For The Quarter And Year Ended 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc59a1b6-ce1a-4572-880c-4d6f39bf3147.pdf) |
| 2025-02-10 | [Regulation 33(3) Of SEBI (LODR) Regulations 2015 - Submission Of Standalone & Consolidated Unaudited Financial Results Along With Limited Review Report For The Quarter And Nine Months Ended On 31St De](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aff5ac0a-6761-4730-adb2-c68d08f10c79.pdf) |
| 2024-11-11 | [Regulation 33(3) Of SEBI (LODR) Regulations, 2015 - Submission Of Standalone & Consolidated Unaudited Financial Results Along With Limited Review Report, Statement Of Assets And Liabilities And Cash Flow For The Quarter And Half Year Ended On 30Th September, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a99fa50-98df-42b8-a356-27d55a30cfb2.pdf) |
| 2024-08-12 | [Regulation 33(3) Of SEBI (LODR) Regulations, 2015- Submission Of The Un-Audited Standalone And Consolidated Financial Results Along With Limited Review Report Thereon For The Quarter Ended 30Th June, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db0cb83c-da8a-4daa-b94f-64d533fd302e.pdf) |
| 2024-05-17 | [Regulation 33(3)(D) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 - Submission Of Standalone & Consolidated Audited Financial Results Along With Audit Report, Statement Of Assets And Liabilities And Cash Flow For The Year Ended On 31St March, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=305c47ea-4ad0-4ee3-a937-2358c7528439.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Jan - Certificate for compliance of regulation 74(5) of the SEBI (Depositories and participants) regulation, 2018 for the quarter ended 31st December, 2025. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Jan - Certificate for compliance of regulation 74(5) of the SEBI (Depositories and participants) regulation, 2018 for the quarter ended 31st December, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/59f0e8c1-72f5-4bc9-a864-659e6b9b0ca0.pdf) |
| 8 Jan - Certificate for compliance of regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended 31st December, 2025 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Jan - Certificate for compliance of regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended 31st December, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c4e6ba2c-6eb7-4ff1-a562-9784cb7b9e4a.pdf) |
| 7 Apr - Syncom confirms it is not a large corporate; annual disclosure for FY2026 not applicable. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 7 Apr - Syncom confirms it is not a large corporate; annual disclosure for FY2026 not applicable.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f9753514-dac7-4f10-b121-3e30d7af36f1.pdf) |
| 7 Apr - Submitted Regulation 74(5) compliance certificate for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Submitted Regulation 74(5) compliance certificate for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/87e09894-8d0d-494f-839c-b70f21d72b45.pdf) |
| 6 Apr - Promoters filed yearly Regulation 31(4) SAST disclosure for FY2026 with audit committee and exchanges. | [Forwarding Yearly Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations, 2011 By The Promoters Along With Their Person Acting In Concert('PAC') Of The Company For The Financial Year Ended On 31St March, 2026. 6 Apr - Promoters filed yearly Regulation 31(4) SAST disclosure for FY2026 with audit committee and exchanges.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a7f5563b-968a-4eb7-9029-8872c9bca0bf.pdf) |
| 4 May - Syncom Formulations acquired entire 7th Floor, Trade Star, Mumbai for Rs 57.26 crore. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 Read With Master SEBI Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 Dated 30Th January, 2026. 4 May - Syncom Formulations acquired entire 7th Floor, Trade Star, Mumbai for Rs 57.26 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c5ac3c07-9993-48e0-ae88-b4f2c91dd105.pdf) |
| 4 May - Syncom Formulations acquired entire 7th Floor, Trade Star, Mumbai for Rs 57.26 crore. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 Read With Master SEBI Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 Dated 30Th January, 2026. 4 May - Syncom Formulations acquired entire 7th Floor, Trade Star, Mumbai for Rs 57.26 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/c5ac3c07-9993-48e0-ae88-b4f2c91dd105.pdf) |
| 4 Feb - Board meeting 12 Feb 2026 3:00 PM to approve unaudited Q3 and nine-month financial results. | [Board Meeting Intimation for Intimation Of Holding 5/2025-26 Board Meeting For Consideration And Approval Of The Standalone And Consolidated Unaudited Financial Results, For The Quarter Ended On 31St December, 2025. 4 Feb - Board meeting 12 Feb 2026 3:00 PM to approve unaudited Q3 and nine-month financial results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/54f4cfd6-51f9-412d-8353-0b012e0bc794.pdf) |
| 3 Apr - Syncom confirms it is not a Large Corporate; annual disclosure for FY2026 not applicable. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 3 Apr - Syncom confirms it is not a Large Corporate; annual disclosure for FY2026 not applicable.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fbf82607-f19d-45e4-b6f2-0b884caaefd9.pdf) |
| 25 Mar - Trading window closed from 1 April 2026 until 48 hours after audited results for quarter/year ended 31 March 2026. | [Closure of Trading Window 25 Mar - Trading window closed from 1 April 2026 until 48 hours after audited results for quarter/year ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/de3c9edf-56f1-46cf-ba37-2061bf561da5.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7de1bff9-791e-4cca-b894-3d625f0b957e.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8768ef6d-4522-4e05-92ee-7167166aa573.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e4404710-d435-4212-9368-e03461ccf901.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524470/74845524470.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524470/71165524470.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/524470/65782524470.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/524470/5244700319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/524470/5244700318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/524470/5244700317.pdf) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/524470/5244700316.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:59:16.270Z.